Overview

Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031

Status:
Active, not recruiting

Trial end date:
2024-10-01

Target enrollment:

Participant gender:

Summary

Open Label Extension Study of Voxelotor Clinical Trial Participants with Sickle Cell Disease Who Participated in Voxelotor Clinical Trials

Phase:

Phase 3

Details

Lead Sponsor:

Global Blood Therapeutics